Skip to main content

Table 1 Baseline characteristics of the patients

From: A comparison of safety and efficacy between long-term DAPT and intensive statins combined with short-term DAPT for acute ischemic stroke

Characteristic

All cases

(n = 220)

Control group

(n = 102)

Study group

(n = 118)

Z/χ2

P-Value

Age (IQR)/year

65.50 (58.00, 76.00)

65.00 (57.75–76.00)

66.00 (58.00–76.00)

−0.082

0.935

Female (n, %)

53 (24.09)

25 (24.51)

28 (23.73)

0.018

0.893

SBP (IQR)/mmHg

154.00 (140.00, 172.0)

155.50 (138.00–176.00)

154.00 (142.75–170.50)

−0.398

0.690

DBP (IQR)/mmHg

90.00 (80.00, 103.00)

89.00 (77.50–103.00)

90.00 (81.00–103.00)

−1.113

0.266

OMT (IQR)/h

16.00 (5.00, 36.00)

13.00 (4.75–27.00)

18.00 (5.00–48.00)

−0.761

0.447

bNIHSS (IQR)

4.00 (3.00, 5.00)

4.00 (3.00–5.00)

4.00 (3.00–4.25)

−1.223

0.221

Medical history (n, %)

Hypertension

184 (83.64)

85 (83.33)

99 (83.90)

0.013

0.910

Diabetes

93 (42.27)

45 (44.12)

48 (40.68)

0.265

0.607

Hyperlipidemia

38 (17.27)

19 (18.63)

19 (16.10)

0.244

0.621

Atrial fibrillation

31 (14.09)

16 (15.69)

15 (12.71)

0.400

0.527

Prior ischemic stroke

69 (31.36)

32 (31.37)

37 (31.36)

0.000

0.998

Prior antiplatelet

72 (32.73)

37 (36.27)

35 (29.66)

1.087

0.297

Median baseline of various enzymology before medication (IQR) – U/L

ALT

16.80 (12.20, 23.40)

17.55 (11.95–25.08)

16.45 (12.73–22.30)

−0.238

0.812

AST

16.60 (12.80, 21.65)

15.95 (11.78–20.93)

17.15 (13.55–22.00)

−1.494

0.135

LDH

171.00 (149.00, 200.00)

173.50 (150.00–200.00)

170.00 (147.50–200.25)

−0.713

0.476

CK

74.50 (54.25, 105.50)

75.50 (58.75–113.25)

74.50 (52.00–101.25)

−0.825

0.409

Median of various enzymology in 2 weeks (14 ± 3 d) after medication (IQR) – U/L

ALT

17.35 (12.03, 27.18)

18.15 (12.00–27.70)

16.85 (12.00–25.68)

−0.832

0.406

AST

16.40 (13.20, 21.78)

16.10 (13.00–21.25)

16.85 (13.28–22.03)

−0.658

0.510

LDH

168.00 (151.00, 187.00)

168.00 (152.75–187.00)

168.00 (147.50–188.25)

−0.219

0.827

CK

71.00 (46.25, 100.00)

66.00 (46.00–95.25)

72.00 (49.00–102.25)

−1.165

0.244

  1. There were no significant differences between study group and control group for any characteristic
  2. SBP systolic blood pressure, DBP diastolic blood pressure, OMT onset to medication time, bNIHSS the baseline score of National Institutes of Health Stroke Scale, ALT alanine aminotransferase, AST aspartate aminotransferase, LDH lactate dehydrogenase, CK creatine kinase